GSA Capital Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-518
Closed -$216K 1477
2022
Q3
$216K Buy
+518
New +$216K 0.03% 1172
2022
Q1
Sell
-498
Closed -$376K 1412
2021
Q4
$376K Buy
+498
New +$376K 0.05% 786
2020
Q3
Sell
-824
Closed -$372K 1245
2020
Q2
$372K Buy
+824
New +$372K 0.21% 123
2019
Q4
Sell
-1,907
Closed -$635K 1433
2019
Q3
$635K Buy
+1,907
New +$635K 0.09% 404
2018
Q4
Sell
-3,568
Closed -$1.12M 1358
2018
Q3
$1.12M Sell
3,568
-225
-6% -$70.4K 0.06% 614
2018
Q2
$1.09M Buy
3,793
+1,747
+85% +$504K 0.05% 701
2018
Q1
$512K Sell
2,046
-1,826
-47% -$457K 0.03% 1047
2017
Q4
$924K Buy
+3,872
New +$924K 0.06% 630
2017
Q3
Sell
-1,314
Closed -$297K 1604
2017
Q2
$297K Buy
+1,314
New +$297K 0.02% 1281
2016
Q3
Sell
-2,590
Closed -$370K 1770
2016
Q2
$370K Buy
+2,590
New +$370K 0.02% 1266
2016
Q1
Sell
-6,390
Closed -$886K 1673
2015
Q4
$886K Sell
6,390
-112
-2% -$15.5K 0.04% 788
2015
Q3
$873K Buy
6,502
+4,503
+225% +$605K 0.04% 750
2015
Q2
$301K Sell
1,999
-5,801
-74% -$873K 0.01% 1612
2015
Q1
$1.05M Buy
7,800
+1,700
+28% +$230K 0.04% 824
2014
Q4
$735K Buy
+6,100
New +$735K 0.05% 676
2014
Q1
Sell
-3,200
Closed -$396K 1560
2013
Q4
$396K Sell
3,200
-200
-6% -$24.8K 0.03% 1009
2013
Q3
$400K Buy
3,400
+1,500
+79% +$176K 0.03% 936
2013
Q2
$213K Buy
+1,900
New +$213K 0.03% 1056